N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.
文献类型：期刊论文
| 作者 | Chen, Shulun; Guo, Wei; Sun, Pu; Meng, Linghua ; Zhang, Ao
|
| 刊名 | CANCER IMMUNOLOGY RESEARCH
 |
| 出版日期 | 2020-03-01 |
| 卷号 | 8期号:3页码:51-51 |
| ISSN号 | 2326-6066 |
| WOS研究方向 | Oncology ; Immunology |
| 语种 | 英语 |
| WOS记录号 | WOS:000518188200074 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/281340]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | Chinese Acad Sci, SIMM, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chen, Shulun,Guo, Wei,Sun, Pu,et al. N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.[J]. CANCER IMMUNOLOGY RESEARCH,2020,8(3):51-51. |
| APA | Chen, Shulun,Guo, Wei,Sun, Pu,Meng, Linghua,&Zhang, Ao.(2020).N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors..CANCER IMMUNOLOGY RESEARCH,8(3),51-51. |
| MLA | Chen, Shulun,et al."N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.".CANCER IMMUNOLOGY RESEARCH 8.3(2020):51-51. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。